|
Ligand ID | QTY |
InChI | InChI=1S/C32H48N10O16/c43-9-17-23(49)25(51)27(53)31(57-17)35-21(47)3-1-19(45)33-5-13-7-41(39-37-13)15-11-55-30-16(12-56-29(15)30)42-8-14(38-40-42)6-34-20(46)2-4-22(48)36-32-28(54)26(52)24(50)18(10-44)58-32/h7-8,15-18,23-32,43-44,49-54H,1-6,9-12H2,(H,33,45)(H,34,46)(H,35,47)(H,36,48)/t15-,16-,17+,18+,23-,24-,25-,26-,27+,28+,29+,30+,31+,32+/m0/s1 |
InChIKey | WUNJKQMXDITVGU-ADJUJXGJSA-N |
SMILES | Software | SMILES |
---|
ACDLabs 12.01 | C1(C(C(O)C(O)C(O1)CO)O)NC(=O)CCC(NCc2nnn(c2)C3COC6C3OCC6n4nnc(c4)CNC(=O)CCC(NC5OC(CO)C(C(C5O)O)O)=O)=O | OpenEye OEToolkits 1.7.6 | c1c(nnn1C2COC3C2OCC3n4cc(nn4)CNC(=O)CCC(=O)NC5C(C(C(C(O5)CO)O)O)O)CNC(=O)CCC(=O)NC6C(C(C(C(O6)CO)O)O)O | CACTVS 3.385 | OC[CH]1O[CH](NC(=O)CCC(=O)NCc2cn(nn2)[CH]3CO[CH]4[CH](CO[CH]34)n5cc(CNC(=O)CCC(=O)N[CH]6O[CH](CO)[CH](O)[CH](O)[CH]6O)nn5)[CH](O)[CH](O)[CH]1O | CACTVS 3.385 | OC[C@H]1O[C@@H](NC(=O)CCC(=O)NCc2cn(nn2)[C@H]3CO[C@@H]4[C@H](CO[C@H]34)n5cc(CNC(=O)CCC(=O)N[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)nn5)[C@H](O)[C@@H](O)[C@H]1O | OpenEye OEToolkits 1.7.6 | c1c(nnn1[C@H]2CO[C@H]3[C@@H]2OC[C@@H]3n4cc(nn4)CNC(=O)CCC(=O)N[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)CNC(=O)CCC(=O)N[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)CO)O)O)O |
|
Formula | C32 H48 N10 O16 |
Name | N-[[1-[(3S,3aR,6S,6aR)-6-[4-[[[4-[[(2R,3R,4S,5R,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]amino]-4-oxidanylidene-butanoyl]amino]methyl]-1,2,3-triazol-1-yl]-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]-1,2,3-triazol-4-yl]methyl]-N'-[(2R,3R,4S,5R,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]butanediamide |
ChEMBL | |
DrugBank | |
ZINC |
|
PDB chain | 6vav Chain B Residue 301
[Download ligand structure]
[Download structure with residue number starting from 1]
[View ligand structure]
|
|
|